{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04429308",
            "orgStudyIdInfo": {
                "id": "STU00211723"
            },
            "organization": {
                "fullName": "Northwestern University",
                "class": "OTHER"
            },
            "briefTitle": "PDT vs Peels for Treatment of Actinic Keratoses",
            "officialTitle": "PDT Versus the Combination of Jessner's Solution and 35% TCA for Treatment of Actinic Keratoses on Upper Extremities: A Randomized Controlled Split-arm Trial",
            "therapeuticArea": [
                "Other"
            ],
            "study": "pdt-vs-peels-for-treatment-of-actinic-keratoses"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-06-10",
            "studyFirstSubmitQcDate": "2020-06-10",
            "studyFirstPostDateStruct": {
                "date": "2020-06-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-14",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Murad Alam",
                "investigatorTitle": "Professor of Dermatology",
                "investigatorAffiliation": "Northwestern University"
            },
            "leadSponsor": {
                "name": "Northwestern University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to to compare photodynamic therapy (PDT) versus the combination of Jessner's solution and 35% trichloroacetic acid (TCA) chemical peels for the treatment of actinic keratoses on upper extremities.\n\nThis is a randomized clinical trial. Approximately 60 participants with actinic keratoses on both upper arms will be randomized to have one arm receive photodynamic therapy, while the contralateral arm receives Jessner's solution followed immediately by 35% TCA. AKs will be counted before treatment and 2-8 weeks after treatment. This study is a pilot study designed to determine the feasibility of this procedure.\n\nSubjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment."
        },
        "conditionsModule": {
            "conditions": [
                "Actinic Keratoses"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Photodynamic Therapy",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "One upper arm will be exposed to blue light therapy",
                    "interventionNames": [
                        "Procedure: Photodynamic Therapy"
                    ]
                },
                {
                    "label": "Chemical Peels",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "One upper arm will be exposed to Jessner's Solution AND 35% Trichloroacetic acid peel",
                    "interventionNames": [
                        "Drug: Chemical Peels"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Photodynamic Therapy",
                    "description": "Photodynamic Therapy consists of (Levulan Kerastick (aminolevulinic acid HCL) topical solution, 20% + BLU-U Photodynamic Light Therapy)",
                    "armGroupLabels": [
                        "Photodynamic Therapy"
                    ],
                    "otherNames": [
                        "PDT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Chemical Peels",
                    "description": "Chemical peels consists of a combination of Jessner's Solution: Composed of Salicylic Acid (14%), Medical Grade Lactic Acid (14%), Medical Grade Resorcinol (14%), Denatured Ethyl Alcohol AND 35% Trichloroacetic acid peels",
                    "armGroupLabels": [
                        "Chemical Peels"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of total AKs cleared",
                    "description": "Percentage of total AKs cleared will be calculated by counting the number of AKs before treatment and 2-8 weeks after treatments.",
                    "timeFrame": "2-8 weeks after treatments"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. \\>18 years of age\n2. Interested in receiving treatment for actinic keratoses on the bilateral upper arms\n3. In good general health as assessed by the investigator\n4. Participants must have the ability to understand and the willingness to sign a written informed consent prior to registration on study\n\nExclusion Criteria:\n\n1. Patient pregnant or nursing\n2. Patient with extensive concurrent skin conditions (such as eczema, psoriasis, etc) on upper extremities that would interfere with treatment as determined by the treating physician\n3. Subject unwilling to sign an IRB approved consent form\n4. Participants who are unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function are not eligible",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alejandra Onate, M.S.",
                    "role": "CONTACT",
                    "email": "onate@northwestern.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Murad Alam, MD",
                    "affiliation": "Northwestern University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Northwestern University Department of Dermatology",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Murad Alam, MD",
                            "role": "CONTACT",
                            "phone": "312-695-6785",
                            "email": "m-alam@northwestern.edu"
                        },
                        {
                            "name": "Murad Alam, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000055623",
                    "term": "Keratosis, Actinic"
                },
                {
                    "id": "D000007642",
                    "term": "Keratosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000011230",
                    "term": "Precancerous Conditions"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M28268",
                    "name": "Keratosis, Actinic",
                    "asFound": "Actinic Keratosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10668",
                    "name": "Keratosis",
                    "asFound": "Keratosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14111",
                    "name": "Precancerous Conditions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M3960",
                    "name": "Aminolevulinic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M21989",
                    "name": "Salicylic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}